Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Employment agrmnt
Director departure
Quarterly results

TG THERAPEUTICS, INC. (TGTX) Create: Alert

All | News | Filings
Date FiledTypeDescription
09/29/2023 4 Lonial Sagar (Director) has filed a Form 4 on TG THERAPEUTICS, INC.
Txns: Granted 20,000 shares @ $0
09/29/2023 4 Hoberman Kenneth (Director) has filed a Form 4 on TG THERAPEUTICS, INC.
Txns: Granted 20,000 shares @ $0
08/14/2023 4 WEISS MICHAEL S (CEO and President) has filed a Form 4 on TG THERAPEUTICS, INC.
Txns: Bought 100,000 shares @ $10.13, valued at $1M
08/04/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/01/2023 8-K Quarterly results
06/05/2023 4 Power Sean A (CFO) has filed a Form 4 on TG THERAPEUTICS, INC.
Txns: Sold 73,647 shares @ $26.7, valued at $2M
06/02/2023 144 Form 144 - Report of proposed sale of securities:
05/08/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/01/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
05/01/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
05/01/2023 8-K Quarterly results
04/21/2023 PRE 14A Form PRE 14A - Other preliminary proxy statements:
04/03/2023 SC 13G Darwin Global Management, Ltd. reports a 7.1% stake in TG Therapeutics, Inc.
03/14/2023 4 Power Sean A (CFO) has filed a Form 4 on TG THERAPEUTICS, INC.
Txns: Granted 85,000 shares @ $0
03/14/2023 4 WEISS MICHAEL S (CEO and President) has filed a Form 4 on TG THERAPEUTICS, INC.
Txns: Granted 985,000 shares @ $0
03/01/2023 10-K Annual Report for the period ended December 31, 2022
02/28/2023 8-K Quarterly results
02/09/2023 SC 13G/A FMR LLC reports a 4.9% stake in TG THERAPEUTICS INC
02/09/2023 SC 13G/A VANGUARD GROUP INC reports a 10.7% stake in TG Therapeutics Inc.
02/01/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
01/06/2023 4 Echelard Yann (Director) has filed a Form 4 on TG THERAPEUTICS, INC.
Txns: Bought 9,000 shares @ $10.64, valued at $95.8k
01/06/2023 4 Charney Laurence N (Director) has filed a Form 4 on TG THERAPEUTICS, INC.
Txns: Sold 30,000 shares @ $11.1, valued at $333k
12/28/2022 8-K Quarterly results
11/10/2022 8-K Quarterly results
11/09/2022 10-Q Quarterly Report for the period ended September 30, 2022
10/11/2022 SC 13G/A VANGUARD GROUP INC reports a 10.2% stake in TG Therapeutics Inc.
09/02/2022 S-3ASR Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
08/09/2022 10-Q Quarterly Report for the period ended June 30, 2022
08/08/2022 8-K Quarterly results
07/22/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/22/2022 4 Power Sean A (CFO) has filed a Form 4 on TG THERAPEUTICS, INC.
Txns: Granted 75,000 shares @ $0
Granted 200,000 options to buy @ $7, valued at $1.4M
07/22/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/22/2022 4 HUME DANIEL (Director) has filed a Form 4 on TG THERAPEUTICS, INC.
Txns: Granted 43,732 shares @ $0
07/22/2022 4 Hoberman Kenneth (Director) has filed a Form 4 on TG THERAPEUTICS, INC.
Txns: Granted 43,732 shares @ $0
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy